USPTO Examiner PARK EVELYN GRACE - Art Unit 3791

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18623941WEARABLE DEVICE FOR NONINVASIVE BODY TEMPERATURE MEASUREMENTApril 2024April 2025Allow1310YesNo
18597536ELECTRONIC DEVICE AND ESTIMATION SYSTEMMarch 2024October 2025Abandon2020YesNo
18593845BLOOD GLUCOSE STATES BASED ON SENSED BRAIN ACTIVITYMarch 2024October 2025Allow1930YesNo
18593847BLOOD GLUCOSE STATES BASED ON SENSED BRAIN ACTIVITYMarch 2024February 2025Allow1120YesNo
18517879Wearable Patch Device for Core Body Temperature MeasurementsNovember 2023June 2024Allow710NoNo
17273477SEIZURE DETECTION SYSTEM IN MOBILE SUBJECTSAugust 2023January 2024Abandon3401NoNo
18446181METHOD AND APPARATUS FOR MONITORING THE CONDITION OF A SOOTHING SEAT FOR AN INFANTAugust 2023September 2025Allow2530YesNo
17975144TRANSNASAL AND TRANSORAL NASOPHARYNGEAL DIAGNOSTICS AND THERAPEUTICSOctober 2022March 2026Abandon4010NoNo
17958307SMARTPHONE APPLICATION WITH POP-OPEN SOUNDWAVE GUIDE FOR DIAGNOSING OTITIS MEDIA IN A TELEMEDICINE ENVIRONMENTSeptember 2022December 2025Allow3811YesNo
17883629DEVICE AND METHOD FOR ACQUIRING BRAIN ELECTRICAL SIGNALAugust 2022March 2026Abandon4310NoNo
17739262SPHYGMOMANOMETER, BLOOD PRESSURE MEASUREMENT METHOD, AND COMPUTER-READABLE RECORDING MEDIUMMay 2022October 2025Allow4110NoNo
17774687Methods And Systems For Placement Of An Electrode Array During An Intracranial ElectroencephalogramMay 2022June 2025Abandon3710NoNo
17763319METHODS AND SYSTEMS FOR ASSESSING SEVERITY OF RESPIRATORY DISTRESS OF A PATIENTMarch 2022February 2026Abandon4620NoNo
17642601A BIOPSY ARRANGEMENTMarch 2022January 2026Allow4620NoNo
17592863PALPATION SUPPORT DEVICE AND PALPATION SUPPORT METHODFebruary 2022March 2026Allow4930NoNo
17619628SAMPLE COLLECTION DEVICEDecember 2021March 2025Abandon3901NoNo
17596316TEMPERATURE MEASUREMENT DEVICE AND SYSTEM FOR DETERMINING A DEEP INTERNAL TEMPERATURE OF A HUMAN BEINGDecember 2021November 2025Allow4720YesNo
17596217SYSTEMS AND METHODS FOR ANALYZING FREQUENCY-FOLLOWING RESPONSE TO EVALUATE CENTRAL NERVOUS SYSTEM FUNCTIONDecember 2021August 2025Allow4410NoNo
17533479METHOD FOR DETERMINING THE METABOLIC PARAMETERS OF A SUBJECTNovember 2021September 2025Abandon4520NoNo
17512701METHOD FOR BLOOD PRESSURE MEASUREMENTOctober 2021February 2025Abandon3910NoNo
17511216Portable Isometric Neck Assessment System and MethodOctober 2021July 2025Allow4520YesNo
17502809BREATH SENSING DEVICEOctober 2021July 2024Abandon3320NoNo
17489966FLUID RESPONSIVENESS DETECTION DEVICE AND METHODSeptember 2021November 2025Allow4920YesNo
17598539METHODS AND APPARATUS FOR INSULIN DOSING GUIDANCE AND DECISION SUPPORT FOR DIABETIC PATIENT EXERCISESeptember 2021November 2024Allow3830YesNo
17598687METHOD AND SYSTEM FOR TRACKING MOVEMENT OF A PERSON WITH WEARABLE SENSORSSeptember 2021December 2025Allow5121YesNo
17598139IDENTIFYING AND EXTRACTING ELECTROENCEPHALOGRAM SIGNALSSeptember 2021July 2025Allow4611NoNo
17406086BREATHING MEASUREMENT AND MANAGEMENT USING AN ELECTRONIC DEVICEAugust 2021January 2025Allow4141YesNo
17430414SYSTEM AND METHODS FOR TRACKING BEHAVIOR AND DETECTING ABNORMALITIESAugust 2021July 2024Abandon3520YesNo
17394314AUDIO DETECTION AND MONITORING OF RESPIRATIONAugust 2021October 2025Allow5130YesNo
17427939A SYSTEM AND METHOD FOR DETECTING CHANGES IN HUMAN TISSUESAugust 2021May 2025Allow4520YesNo
17423754INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND PROGRAMJuly 2021March 2025Abandon4420NoNo
17370105Dental Diagnostic AssemblyJuly 2021August 2024Abandon3720NoNo
17420330BLOOD PRESSURE MEASURING APPARATUS, MODEL SETTING DEVICE, AND BLOOD PRESSURE MEASURING METHODJuly 2021April 2025Abandon4620NoNo
17304716METHOD AND DEVICE FOR CORRECTING POSTUREJune 2021August 2024Allow3830NoNo
17345793SYSTEMS AND METHODS FOR DETECTING RESPONSE TO NON-INVASIVE ELECTROMAGNETIC SIGNALSJune 2021March 2024Abandon3310NoNo
17344153SURGICAL SIZER SOUNDJune 2021June 2025Allow4820NoNo
17336188SYSTEMS AND METHODS FOR HYPERTENSION MONITORINGJune 2021February 2026Allow5660YesNo
17325613FREE FLOW FEVER SCREENINGMay 2021September 2024Allow4030YesNo
17313475ELECTRONIC DEVICE AND ESTIMATION SYSTEMMay 2021June 2024Abandon3720NoNo
17306110Systems and Methods for a Mask with User Health SensorsMay 2021December 2023Abandon3110NoNo
17241449MULTI-SENSOR IN-REAL-TIME BLOOD LOSS MONITORApril 2021September 2024Allow4020NoNo
17234824METHOD AND APPARATUS FOR DETECTING RESPIRATORY FUNCTIONApril 2021October 2024Abandon4230NoNo
17283989BODY WEIGHT ESTIMATION DEVICE, BODY WEIGHT ESTIMATION METHOD, AND PROGRAM RECORDING MEDIUMApril 2021March 2025Abandon4820NoNo
17221200MEDICAL SWABApril 2021February 2025Abandon4720NoNo
17207055WEARABLE DEVICE FOR MONITORING HEALTH STATUSMarch 2021May 2025Allow5041YesNo
17206907WEARABLE DEVICE FOR NONINVASIVE BODY TEMPERATURE MEASUREMENTMarch 2021December 2023Allow3320YesNo
17179939PRESSURE-SENSING DEVICESFebruary 2021November 2023Allow3310NoNo
17264949DEVICE FOR AUTOMATICALLY DETECTING LUNG FUNCTION VARIABILITYFebruary 2021June 2025Allow5340YesNo
17161500Hearing Evaluation Systems and Methods Implementing a Spectro-Temporally Modulated Audio SignalJanuary 2021September 2024Abandon4310NoNo
17260970System and Method for Automatic Evaluation of Gait Using Single or Multi-Camera RecordingsJanuary 2021January 2026Allow6050NoNo
17252150MEDICAL IMPLANT, ASSEMBLY FOR IMPLANTING THE MEDICAL IMPLANT AND ASSEMBLY FOR DETECTING AN INTRACORPOREAL MOVEMENT PATTERN WITH THE MEDICAL IMPLANTDecember 2020July 2025Allow5530NoNo
17250168DEVICE FOR USE IN DETERMINING A HYDRATION AND/OR LIPID LEVEL OF SKINDecember 2020September 2025Abandon5740NoNo
17106213METHODS AND SYSTEMS FOR PULSE TRANSIT TIME DETERMINATIONNovember 2020September 2025Abandon5740NoNo
17058859MEASURING DEVICE FOR MEASURING PHYSIOLOGICAL DATA OF A MAMMALNovember 2020June 2025Abandon5530NoNo
17057797CAPILLARY BLOOD COLLECTION DEVICENovember 2020July 2025Abandon5640YesNo
17087167VACUUM TUBE RECEIVER FOR DRAWING BLOOD THROUGH A PERIPHERAL IV CATHETERNovember 2020September 2025Allow5840NoNo
17076884SKIN EVALUATION DEVICE, SKIN EVALUATION SYSTEM, SKIN EVALUATION METHOD, AND NON-TRANSITORY COMPUTER-READABLE RECORDING MEDIUM STORING PROGRAM FOR SKIN EVALUATIONOctober 2020June 2025Allow5550YesNo
17067402MONITORING SKIN HEALTHOctober 2020May 2024Abandon4330YesNo
17045560APPARATUS AND METHODS FOR DETECTION OF THE ONSET AND MONITORING THE PROGRESSION OF CEREBRAL ISCHEMIA TO ENABLE OPTIMAL STROKE TREATMENTOctober 2020November 2023Abandon3810NoNo
17044172Integrated Device for Self-Collecting and Automated Pre-Processing of Biological FluidsSeptember 2020May 2025Allow5630NoNo
17037373Fever DetectorSeptember 2020March 2024Abandon4120NoNo
17032851DIAGNOSTIC ASSISTANCE SYSTEM, DIAGNOSTIC ASSISTANCE METHOD, AND DIAGNOSTIC ASSISTANCE PROGRAMSeptember 2020February 2024Abandon4110NoNo
17041512DEVICE, SYSTEM AND METHOD FOR EXTRACTING PHYSIOLOGICAL INFORMATION INDICATIVE OF AT LEAST ONE VITAL SIGN OF A SUBJECTSeptember 2020March 2023Allow2910NoNo
17041467MODEL SETTING DEVICE, CONTACTLESS BLOOD PRESSURE MEASUREMENT DEVICE, MODEL SETTING METHOD, AND RECORDING MEDIUMSeptember 2020March 2025Abandon5440NoNo
17030436BLOOD PRESSURE MEASUREMENT MODULESeptember 2020June 2023Allow3210NoNo
17030247Pressure Sensing in Portable Electronic DevicesSeptember 2020January 2024Abandon4020YesNo
16948486MACHINE LEARNING OPTIMIZATION OF FLUENCE MAPS FOR RADIOTHERAPY TREATMENTSeptember 2020February 2024Allow4120YesYes
17023148CUFF UNIT AND SPHYGMOMANOMETERSeptember 2020May 2024Allow4420YesNo
16981320ANESTHETIZING MONITORING SYSTEM, UNIT AND METHOD THEREFORESeptember 2020March 2025Allow5450YesNo
17022265BIOLOGICAL INFORMATION DETECTION DEVICE WITH SENSOR AND CONTACT PORTIONS TO BRING SENSOR INTO CONTACT WITH PORTION OF EARSeptember 2020July 2024Allow4640YesNo
17004462BODY TEMPERATURE MONITORING DEVICE, ACCESS CONTROL SYSTEM, AND ACCESS CONTROL METHODAugust 2020May 2025Abandon5640NoNo
16971129AN IMPLANTABLE CARDIOVASCULAR SENSORAugust 2020August 2025Allow6051YesNo
16969986DEVICE FOR THE REMOTE MONITORING OF BODY TEMPERATURE IN CATTLE AND PIGSAugust 2020July 2023Abandon3510NoNo
16965714METHOD FOR DETECTING A CONVERSION FROM MILD COGNITIVE IMPAIRMENT TO ALZHEIMER DISEASEJuly 2020January 2023Allow3000YesNo
16963422HYBRID SENSING BASED PHYSIOLOGICAL MONITORING AND ANALYZING METHOD AND SYSTEMJuly 2020November 2023Abandon4010NoNo
16961902ASSISTANCE IN THE TREATMENT OF CARDIAC INSUFFICIENCYJuly 2020February 2024Abandon4310NoNo
16954721APPARATUS FOR THE DETECTION OF CARBON DIOXIDEJune 2020April 2025Allow5830YesNo
16892840LINER FOR ADHESIVE SKIN PATCHJune 2020April 2025Allow5940YesNo
16881121DEVICES AND METHODS FOR SECURING SURGICAL GUIDE WIRESMay 2020September 2024Abandon5220NoNo
16094637INTENTION DECODING APPARATUS AND INTENTION CONVEYANCE ASSIST APPARATUSSeptember 2019October 2024Allow6030YesNo
16324228SYSTEMS AND METHODS FOR ACCURATE MEASUREMENT OF PROPRIOCEPTIONFebruary 2019August 2024Allow6041YesNo
16300920MULTIPLE LUMEN DEVICENovember 2018August 2024Abandon6011NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner PARK, EVELYN GRACE.

Strategic Value of Filing an Appeal

Total Appeal Filings
1
Allowed After Appeal Filing
0
(0.0%)
Not Allowed After Appeal Filing
1
(100.0%)
Filing Benefit Percentile
11.1%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner PARK, EVELYN GRACE - Prosecution Strategy Guide

Executive Summary

Examiner PARK, EVELYN GRACE works in Art Unit 3791 and has examined 68 patent applications in our dataset. With an allowance rate of 52.9%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 45 months.

Allowance Patterns

Examiner PARK, EVELYN GRACE's allowance rate of 52.9% places them in the 14% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by PARK, EVELYN GRACE receive 2.44 office actions before reaching final disposition. This places the examiner in the 71% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by PARK, EVELYN GRACE is 45 months. This places the examiner in the 13% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +55.7% benefit to allowance rate for applications examined by PARK, EVELYN GRACE. This interview benefit is in the 95% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 29.3% of applications are subsequently allowed. This success rate is in the 55% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 7.7% of cases where such amendments are filed. This entry rate is in the 8% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 100% percentile among all examiners. Of these withdrawals, 100.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 133.3% are granted (fully or in part). This grant rate is in the 97% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 48% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 5.6% of allowed cases (in the 82% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.